Glyphosate-cancer lawsuit tally doubles to 42,700, as settlement talks attract more plaintiffs, Bayer says

yostlawrounduppage

Germany’s Bayer is now facing 42,700 U.S. plaintiffs blaming its glyphosate-based weedkillers for their cancer, more than twice the tally in July and potentially raising any future settlement.

Bayer, the inventor of aspirin and owner of Yasmin birth control and Claritin allergy relief brands, is widely expected to eventually buy itself out of the litigation, with analysts currently estimating the size of a future settlement at $8-$12 billion.

It put the increase in claims down to a significant increase in plaintiff-side television advertising spending.

“The number of lawsuits, first and foremost, doesn’t tell us anything about their merits,” Chief Executive Werner Baumann said in a media call. “The number of the lawsuits in no way, shape or form is indicative of the amount of the settlement.”

Related article:  Viewpoint: Self-interest, rather than ignorance, key driver in GMO and climate change rejectionism

Bayer had earlier [in October] prepared investors for a surge in cases, saying the prospect of a settlement was fanning efforts by lawyers to recruit plaintiffs.

But Baumann toned down remarks in July that any settlement needed to bring “finality of the overall litigation” from Roundup users, saying instead that finality was an ideal scenario.

Read full, original article: Bayer says U.S. glyphosate plaintiffs more than double since July

Outbreak
Outbreak Daily Digest
Biotech Facts & Fallacies
Genetics Unzipped
Infographic: How dangerous COVID mutant strains develop

Infographic: How dangerous COVID mutant strains develop

Sometime in 2019, probably in China, SARS CoV-2 figured out a way to interact with a specific "spike" on the ...
Untitled

Philip Njemanze: Leading African anti-GMO activist claims Gates Foundation destroying Nigeria

Nigerian anti-GMO activist, physician, and inventor pushes anti-gay and anti-GMO ...
News on human & agricultural genetics and biotechnology delivered to your inbox.
glp menu logo outlined

Newsletter Subscription

Optional. Mail on special occasions.
Send this to a friend